Wyeth Pharmaceutical's Prevnar (pneumococcal 7-valent conjugatevaccine) is now being manufactured in single-dose, prefilledsyringes.
Wyeth Pharmaceutical's Prevnar (pneumococcal 7-valent conjugate vaccine) is now being manufactured in single-dose, prefilled syringes. This new packaging will allow the vaccine to be administered directly from the syringe, thereby reducing the risk for dosing errors. The company will no longer be manufacturing the previously available vials of Prevnar vaccine. The new syringes will be sold in packages of 10.
To see more Hot off the Press news articles, click here click here.
To go to the Drug Topics homepage, click here.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.